Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biopharmaceutics & Drug Disposition|March 27, 2013
Species differences of organic anion transporters involved in the renal uptake of 4-amino-3-chlorophenyl hydrogen sulfate, a metabolite of resatorvid, between rats and dogsToshiyuki Takeuchi, Fumihiro Jinno, Takuya Ebihara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 16, 2019
Characterization of Fasiglifam-Related Liver Toxicity in DogsAkifumi Kogame, Yuu Moriya, Ikuo Mori, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 23, 2011
Absorption, distribution, metabolism and excretion of peginesatide, a novel erythropoiesis-stimulating agent, in ratsKathryn W Woodburn, Christopher P Holmes, Susan D Wilson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2013
Peginesatide clearance, distribution, metabolism, and excretion in monkeys following intravenous administrationKathryn W Woodburn, Kei-Lai Fong, Susan D Wilson, et al.
Biopharmaceutics & Drug Disposition|March 4, 2017
Impact of acute fat mobilisation on the pharmacokinetics of the highly fat distributed compound TAK-357, investigated by physiologically based pharmacokinetic (PBPK) modeling and simulationAkihiko Goto, Yoshihiko Tagawa, Yuu Moriya, et al.
Biopharmaceutics & Drug Disposition|September 27, 2017
Influence of body composition on disposition of the highly fat distributed compound as analysed by physiologically based pharmacokinetic (PBPK) modeling and simulationAkihiko Goto, Yoshihiko Tagawa, Yuu Moriya, et al.
Bioanalysis|August 16, 2023
Development and validation of qPCR methods for nucleic acid biomarkers as a drug development tool: points to considerYuchen Sun, Takahiro Nakamura, Yoshiaki Ohtsu, et al.
Regenerative Therapy|November 11, 2024
Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023Hiroshi Karasawa, Hirokuni Mizoguchi, Bryan Choi, et al.
Cytotherapy|April 25, 2023
Non-clinical, quality and environmental impact assessments of cell and gene therapy products: Report on the 5th Asia Partnership Conference of Regenerative Medicine - April 7, 2022Toshimitsu Tanaka, Hiroshi Karasawa, Masahiko Yasumoto, et al.
Cytotherapy|February 23, 2022
Nonclinical and quality assessment of cell therapy products: Report on the 4th Asia Partnership Conference of Regenerative Medicine, April 15, 2021Tomohiro Yoneda, Toshimitsu Tanaka, Kiyoko Bando, et al.
Pageof 3